Literature DB >> 27257320

Mutation in AIDS restriction gene affecting HIV infection and disease progression in a high risk group from Northeastern India.

Partha Roy1, Sekhar Chakrabarti2.   

Abstract

BACKGROUND: HIV estimates for 2009 released by National AIDS Control Organization (NACO) reveals that 2.4 million people in India were living with HIV, 39% being female, 4.4% children and 82.4% adult males between the age group of 15 and 49 years. Persons with host genetic polymorphism CCR5Δ32 mutation are known to be partially or fully resistant to HIV infection. Persons with mutation affecting both the alleles (homozygous) are resistant to HIV infection whereas single allele (heterozygous) polymorphism leads to slower progression to AIDS. CCR5Δ32 mutation is commoner in Caucasians but less prevalent amongst Africans and Asians thereby rendering them susceptible to HIV infection.
METHOD: 571 HIV serologically naive subjects from a young and homogenous male population hailing from the seven northeastern states; West Bengal and Gorkha people were selected. All the subjects belonged to a special high risk group, sexually active and typically working in difficult and uncongenial terrain involved in frequent moves including overseas missions. Their family lives are severely disrupted. 181 HIV seropositive cases of which 92 cases that were admitted in a large tertiary care hospital were also included. The distribution of CCR5Δ32 polymorphism amongst both HIV seronegative (HSN) and HIV seropositive study cohorts (HSP) using molecular methods was studied. RESULTS AND
CONCLUSION: There was failure to detect any CCR5Δ32 amongst this study group suggesting that this population from the northeastern India, West Bengal and Gorkha people are not protected by this specific host polymorphism in respect of acquisition of HIV infection as well as progression to AIDS.

Entities:  

Keywords:  AIDS restriction gene; CCR5Δ32; Heterozygote; Homozygote for the mutant allele; Homozygote for the normal allele

Year:  2016        PMID: 27257320      PMCID: PMC4878882          DOI: 10.1016/j.mjafi.2015.07.005

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  25 in total

1.  Frequencies of SDF-1 chemokine, CCR-5, and CCR-2 chemokine receptor gene alleles conferring resistance to human immunodeficiency virus type 1 and AIDS in Kuwaitis.

Authors:  A Voevodin; E Samilchuk; S Dashti
Journal:  J Med Virol       Date:  1999-05       Impact factor: 2.327

2.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

3.  Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users.

Authors:  V Alvarez; C López-Larrea; E Coto
Journal:  Hum Genet       Date:  1998-04       Impact factor: 4.132

4.  Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.

Authors:  Romsha Verma; Radha Ballabh Gupta; Kalpana Singh; Rama Bhasin; Abhay Anand Shukla; Shyam S Chauhan; Kalpana Luthra
Journal:  J Clin Virol       Date:  2007-01-19       Impact factor: 3.168

5.  Global distribution of the CCR5 gene 32-basepair deletion.

Authors:  J J Martinson; N H Chapman; D C Rees; Y T Liu; J B Clegg
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

6.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

7.  Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.

Authors:  B Su; G Sun; D Lu; J Xiao; F Hu; R Chakraborty; R Deka; L Jin
Journal:  Eur J Hum Genet       Date:  2000-12       Impact factor: 4.246

8.  Genetic acceleration of AIDS progression by a promoter variant of CCR5.

Authors:  M P Martin; M Dean; M W Smith; C Winkler; B Gerrard; N L Michael; B Lee; R W Doms; J Margolick; S Buchbinder; J J Goedert; T R O'Brien; M W Hilgartner; D Vlahov; S J O'Brien; M Carrington
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

9.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

Review 10.  Human genes that limit AIDS.

Authors:  Stephen J O'Brien; George W Nelson
Journal:  Nat Genet       Date:  2004-06       Impact factor: 38.330

View more
  1 in total

1.  Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria.

Authors:  Ekerette Friday Ekere; Monday F Useh; Henshaw Uchechi Okoroiwu; Tatfeng Youtchou Mirabeau
Journal:  BMC Infect Dis       Date:  2020-01-03       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.